Detalles de la búsqueda
1.
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
Br J Cancer;
122(10): 1461-1466, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32210365
2.
Efficacy and safety of niraparib as maintenance treatment in older patients (≥â¯70â¯years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial.
Gynecol Oncol;
152(3): 560-567, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30638768
3.
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.
Anticancer Drugs;
30(6): 628-635, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31008727
4.
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Lancet Oncol;
13(3): 239-46, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22285168
5.
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Clin Transl Oncol;
25(7): 2090-2098, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708371
6.
Screening for epidermal growth factor receptor mutations in lung cancer.
N Engl J Med;
361(10): 958-67, 2009 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-19692684
7.
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.
Lancet;
374(9699): 1432-40, 2009 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-19767093
8.
Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: final results of a phase II study.
Lung Cancer;
62(1): 62-71, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18440089
9.
Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
J Clin Oncol;
36(13): 1300-1307, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29558274
10.
Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07.
Anticancer Res;
36(12): 6647-6653, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27919997
11.
Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).
J Clin Oncol;
34(21): 2516-25, 2016 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27269942
12.
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.
JAMA Oncol;
1(2): 149-57, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26181014
13.
Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer.
Clin Lung Cancer;
5(6): 360-5, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15217535
14.
Initial activation status of the antioxidant response determines sensitivity to carboplatin/paclitaxel treatment of ovarian cancer.
Anticancer Res;
32(11): 4723-8, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23155235
15.
Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer.
J Clin Oncol;
30(27): 3337-44, 2012 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22753918
16.
SEOM guidelines for the treatment of malignant pleural mesothelioma.
Clin Transl Oncol;
13(8): 569-73, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21821492
17.
Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology Workshop.
Lung Cancer;
74(3): 535-43, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21616552
18.
A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas.
Cancer;
104(8): 1706-12, 2005 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16134177
Resultados
1 -
18
de 18
1
Próxima >
>>